ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
(MM)

(MM) (MELA)

1.12
0.00
( 0.00% )
Updated: 20:00:00

MELA Discussion

View Posts
ThesT ThesT 8 years ago
Pivotal day for MELA. Green skies ahead. glta
👍️0
yaboy520 yaboy520 9 years ago
Im waiting for BK to buy in
👍️0
ThesT ThesT 9 years ago
cdp i'm loading up a bit. hoping i've done my math well.
👍️0
ThesT ThesT 9 years ago
Bonjour Cbd.. Just bought in. This one is elementary math. Revenue should trump dilution. Safe double is what I see.
👍️0
Cbdpotential Cbdpotential 9 years ago
Interesting
I'm watching this one!
👍️0
ThesT ThesT 9 years ago
Nice accumulation today! Looking good.
👍️0
ThesT ThesT 9 years ago
agreed. this more a sales and marketing play. refreshing to not focus on fda, trials, and pump & dump speculations

.75? i'd love to average down with it but i have a hard time seeing -25% with a 9.5M MC and a well documented 15-20M annual revenue coming down the pipeline.

GLTA

👍️0
TheWatcher51 TheWatcher51 9 years ago
I'm waiting for .75.... I like what they have to offer and it's one of the only bios that has a product on market.... Willing to see how it plays out.... Mela
👍️0
ThesT ThesT 9 years ago
make that 15-20M in the next year.
👍️0
ThesT ThesT 9 years ago
Just added MELA. The basics financials show an undervalued stock to me. We have a 9.5M market cap and a (very likely) 30M in revenues coming our way for next year. 45M at .75, I think is a pretty sweet deal.

Opinions on this?
👍️0
TheWatcher51 TheWatcher51 9 years ago
Markets saying sell worthy news... 42 million shares convertible at .75... Don't sound good to me when we are sitting at 1.34.... Mela
👍️0
clydesur clydesur 9 years ago
8:00 am ET June 23, 2015 (Dow Jones) Print

MELA Sciences Acquires XTRAC and VTRAC Businesses From PhotoMedex, Inc.

Becomes a Multi-Product Medical Dermatology Business

Conference Call at 8:30am Eastern Time Today

IRVINGTON, N.Y., June 23, 2015 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), today announced that it has signed and completed the purchase of the XTRAC and VTRAC Dermatology business from PhotoMedex, Inc. for $42.5 million in cash and the assumption of certain business-related liabilities. The purchase price includes all of the accounts receivable, inventory and fixed and intangible assets of the businesses. To fund the purchase price of the transaction, the Company has issued senior secured notes and convertible debentures equal to the transaction purchase price to certain investors. The XTRAC and VTRAC businesses generated $30.6 million in revenues in 2014.

Michael R. Stewart, President and CEO of MELA Sciences, stated, "This is a transformational event for MELA Sciences. As a result of this acquisition, MELA becomes a multi-product company with a single salesforce focused on meeting the needs of dermatologists for the diagnosis and treatment of serious dermatological conditions. The XTRAC laser in particular provides us with a recurring source of revenue that has been growing significantly over the past few years and is expected to generate sufficient cash flow to fund our ongoing operations beginning this year. This should enable us to continue our current commercialization efforts while growing the XTRAC and VTRAC businesses globally.

Added MELA Sciences Chairman, Jeffrey F. O'Donnell, Sr., "I am thrilled we have completed this acquisition as it transforms MELA Sciences into a sustainable commercial enterprise, providing it with a sales infrastructure, a synergistic product line and a positive-cash flow business platform on which to build a leading franchise in medical dermatology. Given Mike Stewart's previous experience running the XTRAC and VTRAC businesses at PhotoMedex, we look forward to a smooth transition with him as CEO of the combined businesses."

XTRAC is an ultraviolet light excimer laser system that has become a widely utilized treatment among dermatologists for the treatment of psoriasis, vitiligo and other skin diseases. The VTRAC Excimer Lamp system, offered internationally, provides targeted therapeutic efficacy demonstrated by excimer technology with the simplicity of design and reliability of a lamp system. In 2014, the acquired businesses generated $30.6 million in revenues, representing year-over-year growth of 41% and a gross profit of 60.1%. As of March 31, 2015, there were 640 installed XTRAC systems in the United States, up from 527 at the end of March 2014. There are approximately 7.5 million people in the U.S. and up to 125 million people worldwide suffering from psoriasis, and 1% to 2% of the world's population have vitiligo. In 2014, over 300,000 XTRAC laser treatments were performed on approximately 19,000 patients in the United States.

To finance the transaction, the Company entered into a securities purchase agreement with institutional investors in connectio
👍️0
TheWatcher51 TheWatcher51 9 years ago
Got my eye on mela... GLA
👍️0
zabigul zabigul 9 years ago
MELA going to breakout soon. Oversold and near breakout levels. Going up up up. :)
👍️0
RichDude RichDude 9 years ago
I missed the real move on 3/10.
👍️0
RichDude RichDude 9 years ago
I missed the real move @ $1.70.
👍️0
MONEYMADE MONEYMADE 9 years ago
MELA is good for 10% IMO
👍️0
RichDude RichDude 9 years ago
MELA just popped up on my screener.
👍️0
PennyStockpick PennyStockpick 9 years ago
debt of 5 million*
👍️0
uptowndw uptowndw 9 years ago
Well it's flaring up now for some reason
👍️0
PennyStockpick PennyStockpick 9 years ago
$MELA also has legal issues facing them " These may include controversies relating to contract claims and employment related matters"
👍️0
PennyStockpick PennyStockpick 9 years ago
My reasons to short $MELA**
👍️0
PennyStockpick PennyStockpick 9 years ago
reasons to short $MELA "November 17, 2014, Rose Crane resigned as our President and Chief Executive Officer"
http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=10317128-3511-8425&type=sect&TabIndex=2&dcn=0001193125-14-418582&nav=1&src=Yahoo

$MELA has a debt of 14 million and revenue of 536k cash has always been minus and right now: Change In Cash and Cash Equivalents -4,079
👍️0
uptowndw uptowndw 9 years ago
Looks like it...
👍️0
Goldmind Goldmind 9 years ago
This POS is done
👍️0
BottomBounce BottomBounce 9 years ago
3/12/2015 HC Wainright Reiterated Rating Buy http://www.analystratings.net/stocks/NASDAQ/MELA/?RegistrationCode=SocialMedia-StockTwits
👍️0
BottomBounce BottomBounce 9 years ago
oversold and way undervalued.
👍️0
the_little_farmer the_little_farmer 9 years ago
$MELA shorts getting hurt here nates room is short apply some pressure to them
👍️0
uptowndw uptowndw 9 years ago
Moving north!!!!
👍️0
the_little_farmer the_little_farmer 9 years ago
Less than 6M float gonna squeeze soon !! :) was the same in Gene and Bioc and will be again here.. low float .. when it squeeze it goes hard and fast :) first they let shorts come in and when most of the float is shorts .. whales coming to squeeze :) long in it and i wish i could add 10 k more under 3 :)
👍️0
BottomBounce BottomBounce 9 years ago
new support level 3.21 up from here imo
👍️0
BottomBounce BottomBounce 9 years ago
very nice vol. lots of buying from bottom of the day
👍️0
diannedawn diannedawn 9 years ago
Who won in the end???
Looks like the shorts...

Not saying its RIGHT...
but lets be realistic.

I'm glad to see MELA finally moving north...
I WISH I had averaged down BEFORE the big move.
BUT I can be fairly certain (based on past experience)
that this WILL be shorted back down;
and then, AFTER the hype and commotion has dwindled away,
(read: no one here cares anymore)
I will be able to average down at a reasonable pps,
and watch MELA trade up slow and steady based on merit, not....

It works the same for all these biotechs...
they get good news and it runs up...
then the flippers bail, followed by the shorts taking it down.


👍️0
the_little_farmer the_little_farmer 9 years ago
http://melasciences.com/melanoma
👍️0
the_little_farmer the_little_farmer 9 years ago
$MELA its MelaFind device can save lives because 3.5 Million Cases affecting 2+ million each year get most common C http://stks.co/j1xMg "
👍️0
the_little_farmer the_little_farmer 9 years ago
$MELA shorts confused what a Lesion is? Clue its not a mole. MelaFind non-invasive can assess lesions such as this: oncology.jamanetwork.c"
👍️0
the_little_farmer the_little_farmer 9 years ago
and with GENE it burned just because it was hugely shorted on a little float.. simply . and lot of buyers came to squeeze them .. always easy on a low float you see.. and here could be the same .. all shorts getting trust and shorts all they can but they do forget it is less than 6M float here :) and when all his shorts buyer come and buy buy buy and here comes the squeeze :) simply this fact .. not an expert but easy to see and understand .. it is why i decided to not short this one can be really dangerous with this low 6M outstanding float :) happy trading buddy and take care
👍️0
the_little_farmer the_little_farmer 9 years ago
yes but if you did a DD and read well on $MELA it is not the fact.. anyway ... we all have different opinion as i can see .. have a great day :)
👍️0
the_little_farmer the_little_farmer 9 years ago
with this low float i wish a nice dip to add 10k :) to be long in it .. i am sure we can see in time a 7$+ news yesterday was awesome ..
👍️0
Warrior23 Warrior23 9 years ago
Warrants convert to free trade and can be done in a day
👍️0
the_little_farmer the_little_farmer 9 years ago
i can understand but float is float and warrants is warrants.. two different things :) so on the trading is 6 m float we trade not the warrants :)
👍️0
Fedex11 © Fedex11 © 9 years ago
continuation or pullback i would advise buying some protection to anyone that bought over $3 just to be safe
👍️0
Warrior23 Warrior23 9 years ago
Except Gene had an Aussie fund and this one has 25M warrants with mid 2$ strike price
👍️0
the_little_farmer the_little_farmer 9 years ago
Less than 6 Millions float, full of shorts :) do you know what this mean :) remember Gene .. it started like that and we touched 11$ i think same thing could happen again if we all squeeze those shorts :) will add 10k this morning and will be long i feel we can go to 7$ in time easy with this tiny float and do not forget 17% of the float is owned by institutions .. looks so good to me :)
👍️0
the_little_farmer the_little_farmer 9 years ago
$MELA Anti-Cancer Biotech 6M float Stock Skyrockets http://www.wallstreetsectorselector.com/investment-articles/editors-desk/2015/03/another-anti-cancer-biotech-stock-skyrockets/
👍️0
MONEYMADE MONEYMADE 9 years ago
,,,,,,,THANKS!
👍️0
BottomBounce BottomBounce 9 years ago
$MELA https://www.google.com/search?q=MELAFIND&source=lnms&tbm=isch&sa=X&ei=u1EBVaHSGdG1sAT-ioHQDA&ved=0CAkQ_AUoAw
👍️0
BottomBounce BottomBounce 9 years ago
$MELA MACD Bullish CrossOver Chart
👍️0
BottomBounce BottomBounce 9 years ago
Melanoma skin cancers

"Melanoma is a cancer that begins in the melanocytes. Other names for this cancer include malignant melanoma and cutaneous melanoma. Because most melanoma cells still make melanin, melanoma tumors are usually brown or black. But some melanomas do not make melanin and can appear pink, tan, or even white.

Melanomas can occur anywhere on the skin, but they are more likely to start in certain locations. The trunk (chest and back) is the most common site in men. The legs are the most common site in women. The neck and face are other common sites.

Having darkly pigmented skin lowers your risk of melanoma at these more common sites, but anyone can develop this cancer on the palms of the hands, soles of the feet, and under the nails. Melanomas in these areas account for more than half of all melanomas in African Americans but fewer than 1 in 10 melanomas in whites.

Melanomas can also form in other parts of your body such as the eyes, mouth, genitals and anal area, but these are much less common than melanoma of the skin.

Melanoma is much less common than basal cell and squamous cell skin cancers, but it is far more dangerous. Like basal cell and squamous cell cancers, melanoma is almost always curable in its early stages. But it is much more likely than basal or squamous cell cancer to spread to other parts of the body if not caught early." http://www.cancer.org/cancer/skincancer-melanoma/detailedguide/melanoma-skin-cancer-what-is-melanoma
👍️0
aapples1992 aapples1992 9 years ago
Insiders loaded the boat from .50 to 1.35 wow bought over 3 million shares wow...writing was on the wall here
$5.00 tomorrow
👍️0

Your Recent History

Delayed Upgrade Clock